The COVID-19 pandemic has brought the importance of epidemic preparedness sharply into focus. An unforeseen disease outbreak can have dire consequences for public health, economic growth, and social wellbeing. At ID Labs, research is ongoing into the various aspects of epidemic preparedness from biological, immunological, and biomedical perspectives. These efforts cover a broad range of approaches, including detection and surveillance of emerging pathogens, diagnostic technologies for tracking disease spread, and rapid development and deployment of novel therapeutics and vaccines.
ID Labs is applying the lessons learned from COVID-19 to develop new methods for epidemic response, bringing together an international team of researchers into a collaborative force for public health. Our scientists are discovering biomarkers for vaccine immune monitoring, building new models to understand disease pathogenesis, characterising host-pathogen interactions for the development of broad-spectrum antivirals, developing new point-of-care diagnostics for rapid disease monitoring, and even applying social sciences and computational resources to the problems of outbreak surveillance.

Together, ID Labs scientists are working to ensure that the world is ready for the next pandemic.